Skip to content
Cerevention
  • Products
    • MindsEye™ Expandable Port
    • Neurapheresis™ CSF Management System
    • DepiCT™ Neuroimaging Platform
  • Company
    • News
  • Contact

News

October 8, 2018 | News

Minnetronix Neuro Launches Global Neurapheresis™ Research Consortium

Collaborative effort will accelerate development of novel therapies for underserved diseases involving the central nervous system

Read Article
October 1, 2018 | News

Minnetronix Neuro Successfully Completes First Clinical Study in Hemorrhagic Stroke

Minnesota-based Company to Present at Late Breaking Session during Congress of Neurological Surgeons

Read Article
September 10, 2018 | News

Contract med-tech manufacturer Minnetronix to launch own device

Minnetronix is developing a product that removes contaminants in the cerebral spinal fluid after a hemorrhagic stroke.

Read Article
October 4, 2017 | News

Feasibility of Neurapheresis™ Therapy for Multidrug Resistant Gram-negative Bacterial Meningitis

October 4, 2017 – Duke University Medical Center/Minnetronix Neuro Pseudomonas, Acinetobacter and Klebsiella are three multidrug resistant (MDR) gram-negative pathogens…

Read Article
October 4, 2017 | News

In Vitro Characterization of the Neurapheresis™ System for the Treatment of Cryptococcal Meningitis

October 4, 2017 – Duke University Medical Center/Minnetronix Neuro Cryptococcal Meningitis is caused by Cryptococcus neoformans and is the most…

Read Article
  • «
  • 1
  • 2
  • 3
  • 4
  • »

Cerevention
1635 Energy Park Drive
St. Paul, MN 55108
P: 651-917-4060
info@cerevention.com

Minnetronix is a trademark of Minnetronix Medical, Inc. MindsEye is a trademark of Minnetronix Neuro, Inc. Cerevention is a trademark of Minnetronix Neuro, Inc.
Caution: Federal (U.S.A.) Law restricts this device to sale by or on the order of a physician.

Neurapheresis is a trademark of Minnetronix Neuro, Inc.
Caution: Investigational Device. Limited by Federal (U.S.A.) law to investigational use only.

DepiCT is a trademark of Minnetronix Neuro, Inc.
DepiCT Neuroimaging Platform is currently under development. All subsequent material represents intended use.

LinkedIn Facebook Twitter Twitter
© 2023 Minnetronix Neuro. All rights reserved.